Collegium Pharmaceutical Inc (COLL) support and resistance · P/E 17, rev $181.9M
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Collegium Pharmaceutical Inc (COLL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new COLL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the COLL quote page for the session range and the stock page for the full model.
Not investment advice.